| scholarly article | Q13442814 |
| P50 | author | William R Tyor | Q88961513 |
| P2093 | author name string | Heather Bimonte-Nelson | |
| P2860 | cites work | Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline | Q33987146 |
| Requirements and selection of an animal model. | Q34173723 | ||
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study | Q34370880 | ||
| Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy | Q34808562 | ||
| Interferon-alpha causes neuronal dysfunction in encephalitis | Q34969111 | ||
| Humanized mouse models for HIV-1 infection of the CNS. | Q35567215 | ||
| Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). | Q35589934 | ||
| Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
| Rodent models for HIV-associated neurocognitive disorders. | Q35803957 | ||
| Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis | Q35968510 | ||
| A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data | Q36441017 | ||
| A model of human immunodeficiency virus encephalitis in scid mice | Q36544848 | ||
| Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. | Q36940756 | ||
| Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study | Q37195984 | ||
| The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model | Q40018266 | ||
| HIV-associated neurocognitive disorders: Five new things | Q40782831 | ||
| HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution | Q40806200 | ||
| The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model | Q42235552 | ||
| Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. | Q42243855 | ||
| HIV-1 clade-specific differences in the induction of neuropathogenesis | Q43251339 | ||
| SCID mice with HIV encephalitis develop behavioral abnormalities | Q44468441 | ||
| Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain | Q44575854 | ||
| The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy | Q45434391 | ||
| The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function | Q45625929 | ||
| Highly active antiretroviral therapy and human immunodeficiency virus encephalitis | Q46456152 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 180-184 | |
| P577 | publication date | 2017-09-11 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments | |
| P478 | volume | 24 |
| Q90335938 | Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro |
| Q64940315 | Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder. |
| Q88185225 | Optimizing animal models for HIV-associated CNS dysfunction and CNS reservoir research |
Search more.